Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.
Giunta EF, Caroli P, Scarpi E, Altavilla A, Rossetti V, Marini I, Celli M, Casadei C, Lolli C, Schepisi G, Bleve S, Brighi N, Cursano MC, Paganelli G, Matteucci F, De Giorgi U. Giunta EF, et al. Among authors: paganelli g. Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):326-334. doi: 10.1007/s00259-024-06887-4. Epub 2024 Aug 29. Eur J Nucl Med Mol Imaging. 2024. PMID: 39207484 Free PMC article.
Multimodal Approach to Outcome Prediction in Metastatic Castration-Resistant Prostate Cancer by Integrating Functional Imaging and Plasma DNA Analysis.
Conteduca V, Scarpi E, Matteucci F, Caroli P, Ravaglia G, Fantini L, Gurioli G, Schepisi G, Wetterskog D, Menna C, Burgio SL, Lolli C, Paganelli G, Attard G, De Giorgi U. Conteduca V, et al. Among authors: paganelli g. JCO Precis Oncol. 2019 Dec;3:1-13. doi: 10.1200/PO.18.00302. JCO Precis Oncol. 2019. PMID: 35100689
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up.
Severi S, Grassi I, Bongiovanni A, Nicolini S, Marini I, Arpa D, Ranallo N, Azzali I, Di Iorio V, Sarnelli A, Manuela M, Amadori E, Fabbri L, Bartolini D, Tosatto L, Di Meco F, Gurrieri L, Riva N, Calabro L, Matteucci F, Paganelli G, Sansovini M. Severi S, et al. Among authors: paganelli g. J Nucl Med. 2024 Sep 3;65(9):1409-1415. doi: 10.2967/jnumed.123.266956. J Nucl Med. 2024. PMID: 39142827 Free PMC article.
Do we need dosimetry for optimization of theranostics in CNS tumors?
Cicone F, Gnesin S, Santo G, Stokke C, Bartolomei M, Cascini GL, Minniti G, Paganelli G, Verger A, Cremonesi M. Cicone F, et al. Among authors: paganelli g. Neuro Oncol. 2024 Oct 1:noae200. doi: 10.1093/neuonc/noae200. Online ahead of print. Neuro Oncol. 2024. PMID: 39351795
Lu-PRRT used more intensively on advanced GEP and lung NENs: preliminary results on toxicity from a randomized study.
Grassi I, Nicolini S, Marini I, Matteucci F, Ranallo N, Di Iorio V, Sarnelli A, Foca F, Monti M, Fabbri L, Fantini L, Rossi A, Paganelli G, Severi S, Sansovini M. Grassi I, et al. Among authors: paganelli g. Neuroendocrinology. 2024 Nov 21:1-20. doi: 10.1159/000542328. Online ahead of print. Neuroendocrinology. 2024. PMID: 39571544 Free article.
Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors.
Bocchini M, Tazzari M, Ravaioli S, Piccinini F, Foca F, Tebaldi M, Nicolini F, Grassi I, Severi S, Calogero RA, Arigoni M, Schrader J, Mazza M, Paganelli G. Bocchini M, et al. Among authors: paganelli g. Front Oncol. 2023 May 23;13:1136331. doi: 10.3389/fonc.2023.1136331. eCollection 2023. Front Oncol. 2023. PMID: 37287922 Free PMC article.
Radioligand therapies in cancer: mapping the educational landscape in Europe.
Bugani V, Battistelli L, Sansovini M, Monti M, Paganelli G, Gich I, Flotats A, Erba PA, Blay JY, la Fougère C, Van Poppel H, Charalambous A, Herrmann K, Giordano A, Györke T, Deroose C, Matteucci F, Carrió I. Bugani V, et al. Among authors: paganelli g. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2692-2698. doi: 10.1007/s00259-023-06217-0. Epub 2023 Apr 14. Eur J Nucl Med Mol Imaging. 2023. PMID: 37058168 Free PMC article.
Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort.
Bonazzetti C, Tazza B, Gibertoni D, Pasquini Z, Caroccia N, Fanì F, Fornaro G, Pascale R, Rinaldi M, Miani B, Gamberini C, Morelli MC, Tamé M, Busutti M, Comai G, Potena L, Borgese L, Salvaterra E, Lazzarotto T, Scudeller L, Viale P, Giannella M; CONTRAST Study Group. Bonazzetti C, et al. Clin Infect Dis. 2023 May 24;76(10):1761-1767. doi: 10.1093/cid/ciad016. Clin Infect Dis. 2023. PMID: 36636955 Free PMC article.
177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials.
Bongiovanni A, Nicolini S, Ibrahim T, Foca F, Sansovini M, Di Paolo A, Grassi I, Liverani C, Calabrese C, Ranallo N, Matteucci F, Paganelli G, Severi S. Bongiovanni A, et al. Among authors: paganelli g. Cancers (Basel). 2022 Dec 7;14(24):6022. doi: 10.3390/cancers14246022. Cancers (Basel). 2022. PMID: 36551507 Free PMC article.
420 results